Viridian Therapeutics Terminates Prior $175 Million Sale Agreement
ReutersMar 4, 2025 11:36 AM
March 4 (Reuters) - Viridian Therapeutics VRDN.O:
VIRIDIAN THERAPEUTICS INC - ENTERS $300 MILLION SALE AGREEMENT WITH JEFFERIES
VIRIDIAN THERAPEUTICS INC - TERMINATES PRIOR $175 MILLION SALE AGREEMENT
Source text: [ID:n0001193125-25-044406]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Alphabet Dodges a Bullet on Antitrust, but It's Still Not Out of the Woods
Key PointsAlphabet is involved in two antitrust cases, one involving search and another related to its ad tech businesses.The judge in the first case has already suggested remedies, but the consequences for the second case have yet to be determined.Investors have been buying up Alphabet's stock nowThe Motley Fool
14 hours ago
Oracle Q1 FY2026 Earnings: Cloud Surge and Record RPO Fuel AI Optimism
TradingKey - Oracle Corporation (NYSE: ORCL) posted mixed Q1 FY2026 results, with total revenue and adjusted EPS slightly below consensus amid a shift to cloud services, but cloud revenue beat expectations with robust 28% growth. A massive RPO backlog of $455 billion, up 359% YoYTradingKey
18 hours ago
U.S. August CPI Preview: Persistent Rise in Inflation, What Impact on Rate Cuts? And on US Stocks?
TradingKey - On 11 September 2025, the U.S. will publish August CPI data. Consensus forecasts indicate a 0.3% month-over-month increase for both headline CPI and core CPI. As a result, headline CPI year-over-year may climb to 2.9%, up from 2.7%TradingKey
Tue, Sep 9
Unlocking Gold’s Next Leg: $4,000 in Reach by 2025？
TradingKey - Gold has kicked off a fresh uptrend in early September, breaking out of months of compression and reclaiming key territory. The decisive move above $3,500 establishes a new support base and puts higher objectives back on the table for the weeks aheadTradingKey
Thu, Sep 4
Tradingkey
